Ignite Creation Date:
2024-05-05 @ 7:16 PM
Last Modification Date:
2024-10-26 @ 9:46 AM
Study NCT ID:
NCT00639522
Status:
UNKNOWN
Last Update Posted:
2009-04-15
First Post:
2008-03-14
Brief Title:
Dose Escalation Study of Liposomal Paclitaxel WithWithout Capecitabine in Patients With Advanced Gastric Carcinoma
Sponsor:
Nanjing Sike Pharmaceutical Co Ltd
Organization:
Nanjing Sike Pharmaceutical Co Ltd
Organization Data
Organization:
Nanjing Sike Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
LPS-GC-01-2008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanjing Sike Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Prof Jinwan Wang
Old Organization:
Cancer Institute and HospitalChinese Academy of Medical Science